Nektar Therapeutics
NKTR
NKTR
233 hedge funds and large institutions have $3.39B invested in Nektar Therapeutics in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 71 increasing their positions, 83 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
233
Holders Change
-10
Holders Change %
-4.12%
% of All Funds
4.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
71
Reduced
83
Closed
34
Calls
$9.18M
Puts
$8.48M
Net Calls
+$701K
Net Calls Change
-$9.48M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$33.2M |
| 2 |
DFO
Duquesne Family Office
New York
|
+$20M |
| 3 |
BlackRock
New York
|
+$13M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.82M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$7.63M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$40.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$22.3M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
-$15.9M |
| 4 |
D.E. Shaw & Co
New York
|
-$11.4M |
| 5 |
Goldman Sachs
New York
|
-$11.4M |
